A significant advance in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This crucial malignant inhibitor protein is frequently disabled in many types of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research